Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|September 5, 1992
Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activationN J Pollock, A M Manelli, C W Hutchins, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2001
Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-years results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk diseaseR G MacKenzie, E Franssen, R Wong, et al.
American Journal of Hypertension|June 1, 1990
A68930: a potent and specific agonist for the D-1 dopamine receptorJ W Kebabian, C Briggs, D R Britton, et al.
The Journal of Biological Chemistry|May 28, 1998
A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteinsK L Lan, N A Sarvazyan, R Taussig, et al.
European Journal of Pharmacology|January 1, 1994
Characterization of the human dopamine D3 receptor expressed in transfected cell linesR G MacKenzie, D VanLeeuwen, T A Pugsley, et al.
Journal of Medicinal Chemistry|November 25, 1994
Studies of the active conformation of a novel series of benzamide dopamine D2 agonistsD J Wustrow, L D Wise, D M Cody, et al.
Journal of Medicinal Chemistry|August 15, 1997
Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
European Journal of Pharmacology|August 14, 1991
Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cellsM E Steffey, G L Snyder, R W Barrett, et al.
Pageof 7